Physician profile
Heather E Coates
NPI 1992740682
$1,739.57
in general payments reported to CMS, 2019-2025
21 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.29 · 2022: $513 · 2023: $432 · 2024: $395 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $450.21 | 2022-2025 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $225.56 | 2022-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $205.73 | 2021-2025 | Airsupra, Breztri |
| Abbvie INC. | $154.27 | 2022-2025 | |
| Lilly USA, LLC | $135.27 | 2022-2025 | Mounjaro, Zepbound |
| Biohaven Pharmaceutical Holding Company LTD. | $74.73 | 2022 | |
| Amgen INC. | $68.10 | 2023-2024 | Otezla, Repatha, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.97 | 2022 | |
| Inspire Medical Systems, INC. | $60.80 | 2024-2025 | Inspire |
| Merck Sharp & Dohme LLC | $53.64 | 2022 | |
| Novartis Pharmaceuticals Corporation | $45.96 | 2021-2023 | |
| Pfizer INC. | $40.02 | 2025 | |
| Abbott Laboratories | $23.98 | 2022 | |
| Sumitomo Pharma America, INC. | $22.31 | 2024 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $20.98 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $19.79 | 2022 | |
| Antares Pharma, INC. | $17.15 | 2025 | Xyosted |
| Exact Sciences Corporation | $15.84 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $13.95 | 2024 | Shingrix |
| Halozyme INC | $13.45 | 2023 | |
| Pharmacosmos Therapeutics INC. | $12.86 | 2023 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Coates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.